News letter February 2023
As we move into the new year, I wanted to take a moment to update you on the exciting developments happening at our organization.
Read moreNews & events
CPHI Frankfurt in November
Zelmic will participate at CPHI Frankfurt on November 1-3, 2022 David Sagna is excited to meet new clients and suppliers to discuss topical drug development and the opportunities with the new IMP topical manufacturing unit. This trip was facilitated in connection with the EU.
Read moreNew Updates In Drug Formulation and Bioavailability
Meet us in Copenhagen 6th of September
http://www.formulationsbioavailability.com/
Read moreZelmic will attend the upcoming Skin Forum 2022 in Malmö, Sweden.
Ph.D. Anna Runnsjö will be present at the upcoming Skin Forum 2022 in Malmö, Sweden.
Read moreThe Future of Swedish and Danish Life Science 2021
Zelmic will attend The Future of Swedish and Danish Life Science on the 2nd of September. David Sagna, CEO, and Ph.D. Susanne Nilsson, Head of Development will be present at the event.
Read moreZelmic AB will attend the 8th NLSDays digital event 2021
David Sagna, CEO and Ph. D Susanne Nilsson, Head of Development, will be present during the event this year.
Read moreAnnual Dermatology Drug Development Summit 2021
MEET US AT 2nd Annual Dermatology Drug Development Summit 2021, 17-19 February, Virtual Event | 9AM – 5PM CET.
Read moreSupporting clients through COVID-19
We are fortunate to be able to remain open and to assist and support our clients’ needs during the fight against COVID-19.
Read more